Survival control of malignant lymphocytes by anti-apoptotic MCL-1

被引：34
作者：
Fernandez-Marrero, Y. [1 ]
Spinner, S. [2 ]
Kaufmann, T. [1 ]
Jost, P. J. [2 ]
机构：
[1] Univ Bern, Fac Med, Inst Pharmacol, Bern, Switzerland
[2] Tech Univ Munich, Klinikum Rechts Isar, Med Dept Hematol & Oncol 3, Ismaningerstr 22, D-81675 Munich, Germany
来源：
LEUKEMIA | 2016年 / 30卷 / 11期
基金：
瑞士国家科学基金会;
关键词：
T-CELL LYMPHOMA; BCL-2 FAMILY PROTEINS; NON-HODGKINS-LYMPHOMA; STRUCTURE-GUIDED DESIGN; GENOME-WIDE ANALYSIS; DOWN-REGULATION; IN-VITRO; B-CELLS; ANAPLASTIC LYMPHOMA; SIGNALING PATHWAY;
D O I：
10.1038/leu.2016.213
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Programmed apoptotic cell death is critical to maintain tissue homeostasis and cellular integrity in the lymphatic system. Accordingly, the evasion of apoptosis is a critical milestone for the transformation of lymphocytes on their way to becoming overt lymphomas. The anti-apoptotic BCL-2 family proteins are pivotal regulators of the mitochondrial apoptotic pathway and genetic aberrations in these genes are associated with lymphomagenesis and chemotherapeutic resistance. Pharmacological targeting of BCL-2 is highly effective in certain indolent B-cell lymphomas; however, recent evidence highlights a critical role for the BCL-2 family member MCL-1 in several lymphoma subtypes. MCL-1 is recurrently highly expressed in various kinds of cancer including non-Hodgkin's lymphoma of B-and T-cell origin. Moreover, both indolent and aggressive forms of lymphoma require MCL-1 for lymphomagenesis and for their continued survival. This review summarizes the role of MCL-1 in B-and T-cell lymphoma and discusses its potential as a therapeutic target.
引用
收藏
页码：2152 / 2159
页数：8
相关论文
共 100 条
  • [11] MCL1 provides a window on the role of the BCL2 family in cell proliferation, differentiation and tumorigenesis
    Craig, RW
    [J]. LEUKEMIA, 2002, 16 (04) : 444 - 454
  • [12] Structural insights into the degradation of Mcl-1 induced by BH3 domains
    Czabotar, Peter E.
    Lee, Erinna F.
    van Delft, Mark F.
    Day, Catherine L.
    Smith, Brian J.
    Huang, David C. S.
    Fairlie, W. Douglas
    Hinds, Mark G.
    Colman, Peter M.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (15) : 6217 - 6222
  • [13] Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy
    Czabotar, Peter E.
    Lessene, Guillaume
    Strasser, Andreas
    Adams, Jerry M.
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2014, 15 (01) : 49 - 63
  • [14] Structure of the BH3 domains from the p53-inducible BH3-only proteins Noxa and Puma in complex with Mcl-1
    Day, Catherine L.
    Smits, Callum
    Fan, F. Cindy
    Lee, Erinna F.
    Fairlie, W. Douglas
    Hinds, Mark G.
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 2008, 380 (05) : 958 - 971
  • [15] DELGAIZO M, 2013, CANC LETT, V332, P202, DOI DOI 10.1016/J.CANLET.2011.12.021
  • [16] Discovery of Marinopyrrole A (Maritoclax) as a Selective Mcl-1 Antagonist that Overcomes ABT-737 Resistance by Binding to and Targeting Mcl-1 for Proteasomal Degradation
    Doi, Kenichiro
    Li, Rongshi
    Sung, Shen-Shu
    Wu, Hongwei
    Liu, Yan
    Manieri, Wanda
    Krishnegowda, Gowdahalli
    Awwad, Andy
    Dewey, Alden
    Liu, Xin
    Amin, Shantu
    Cheng, Chunwei
    Qin, Yong
    Schonbrunn, Ernst
    Daughdrill, Gary
    Loughran, Thomas P., Jr.
    Sebti, Said
    Wang, Hong-Gang
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (13) : 10224 - 10235
  • [17] Mcl-1 promotes survival of thymocytes by inhibition of Bak in a pathway separate from Bcl-2
    Dunkle, A.
    Dzhagalov, I.
    He, Y-W
    [J]. CELL DEATH AND DIFFERENTIATION, 2010, 17 (06) : 994 - 1002
  • [18] The anti-apoptotic Bcl-2 family member Mcl-1 promotes T lymphocyte survival at multiple stages
    Dzhagalov, Ivan
    Dunkle, Alexis
    He, You-Wen
    [J]. JOURNAL OF IMMUNOLOGY, 2008, 181 (01) : 521 - 528
  • [19] The antiapoptotic protein Mcl-1 is essential for the survival of neutrophils but not macrophages
    Dzhagalov, Ivan
    St. John, Ashley
    He, You-Wen
    [J]. BLOOD, 2007, 109 (04) : 1620 - 1626
  • [20] Discovery of Potent Myeloid Cell Leukemia 1 (Mcl-1) Inhibitors Using Fragment-Based Methods and Structure-Based Design
    Friberg, Anders
    Vigil, Dominico
    Zhao, Bin
    Daniels, R. Nathan
    Burke, Jason P.
    Garcia-Barrantes, Pedro M.
    Camper, DeMarco
    Chauder, Brian A.
    Lee, Taekyu
    Olejniczak, Edward T.
    Fesik, Stephen W.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (01) : 15 - 30
12345678910